Skip to main content
. 2011 Jun;46(3):747–767. doi: 10.1111/j.1475-6773.2010.01219.x

Table 3.

Facility Characteristics by Type of Facility (N = 3,419 Facilities)

FP Chain 1 FP Chain 2 FP Chain 3 FP Chain 4 NP Chain 5 FP Nonchain NP Nonchain p-Value
Facility size (avg # patients/facility) 73 (43) 78 (46) 82 (51) 70 (46) 66 (40) 73 (48) 89 (63) <.0001
Ratio of technicians to registered nurses 2.2 (1.5) 2.4 (8.3) 2.7 (1.3) 2.6 (3.7) 1.4 (0.9) 2 (1.7) 1.8 (2) .0001
% White based on facility zip code 70 (24) 67 (26) 68 (25) 72 (23) 74 (23) 70 (25) 73 (24) .0006
GINI coefficient for income inequality* 0.45 (0.04) 0.45 (0.04) 0.45 (0.04) 0.45 (0.03) 0.46 (0.04) 0.45 (0.04) 0.44 (0.03) .0004
Region (%) <.0001
 Northeast (Networks 1–5) 23.0 22.2 18.9 6.3 26.5 25.0 21.5
 Southeast (Networks 6–8, 13, 14) 46.0 40.6 35.0 43.1 42.5 38.2 19.0
 Midwest (Networks 9–12) 19.3 20.2 22.3 34.7 18.8 20.2 27.0
 West (Networks 15–18) 11.7 16.9 23.8 15.9 12.2 16.5 32.5
Urban/rural status .0002
 Rural (% yes) 31.1 25.7 25.7 36.0 39.8 28.6 27.0
 Urban (% yes) 68.9 74.3 74.3 64.0 60.2 71.4 73.0
Facility clinical characteristics
 Use of EPO (average units/month) 85,377 (21,323) 99,354 (23,289) 92,309 (22,791) 86,667 (22,390) 76,398 (19,817) 75,177 (25,538) 75,488 (24,370) <.0001
 Use of iron (average mg/month) 227 (68) 283 (74) 290 (84) 221 (66) 228 (55) 225 (83) 192 (68) <.0001
 Use of Vitamin D (average mcg/month) 43 (15) 52 (17) 47 (19) 35 (13) 18 (12) 29 (16) 26 (13) <.0001
 Use of all three injectable medications* 7.4 (2.1) 9.3 (2.1) 8.7 (2.3) 6.9 (2.3) 5.5 (1.7) 6 (2.2) 5.4 (1.9) <.0001
 % Patients with HCT>33% 91 (7) 92 (9) 93 (7) 92 (7) 90 (9) 88 (13) 89 (12) <.0001
 % Patients with URR>65% 96 (4) 93 (7) 95 (5) 96 (4) 90 (7) 92 (9) 93 (7) <.0001

Notes. Italics indicate significance of 0.05. Numbers in parentheses are standard deviations.

*

Summarized based on the dose quartile distributions with a minimum of 9 and a maximum of 12.

Summarized for every certified facility based on entire 2004 outpatient dialysis claims.

EPO, epoetin; FP, for-profit; HCT, hematocrit; NP, nonprofit; URR, urea reduction ratio.